Ying Tang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ying Tang has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Bai-Feng Zhang
Department of Clinical Oncology, The University of Hong Kong
1 shared publication - Bei-Lei Liu
Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China
1 shared publication - Ching Ngar Wong
Department of Clinical Oncology, Centre for Cancer Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
1 shared publication Hai-Hang Ao
Affiliated Hospital of Ningxia Medical University
1 shared publication- Hongguang Zhao
Zhejiang Cancer Hospital
1 shared publication - Hu
Second Military Medical University
1 shared publication
Latest Publications
- 24 January 2023
- Published by Wolters Kluwer Health in Hepatology
- Vol. 79 (1) , 61-78
Enhanced mitophagy driven by ADAR1-GLI1 editing supports the self-renewal of cancer stem cells in HCC
Background and Aims: Deregulation of adenosine-to-inosine editing by adenosine deaminase acting on RNA 1 (ADAR1) leads to tumor-specific transcriptome diversity with prognostic values for HCC. However, ADAR1 editase-dependent mechanisms governing liver cancer stem cell (LCSC) generation and maintenance have remained elusive. Approach and Results: RNA-seq profiling identified ADAR1-responsive recoding editing events in HCC and showed editing frequency of GLI1, rather than transcript abundance was clinically relevant. Functional differences in LCSC self-renewal and tumor aggressiveness between wild-type (GLI1wt) and edited GLI1 (GLI1edit) were elucidated. We showed that overediting of GLI1 induced an arginine-to-glycine (R701G) substitution, augmenting tumor-initiating potential and exhibiting a more aggressive phenotype. GLI1R701G harbored weak affinity to SUFU, which in turn, promoted its cytoplasmic-to-nuclear translocation to support LCSC self-renewal by increased pluripotency gene expression. Moreover, editing predisposed to stabilize GLI1 by abrogating β-TrCP-GLI1 interaction. Integrative analysis of single-cell transcriptome further revealed hyperactivated mitophagy in ADAR1-enriched LCSCs. GLI1 editing promoted a metabolic switch to oxidative phosphorylation to control stress and stem-like state through PINK1-Parkin-mediated mitophagy in HCC, thereby conferring exclusive metastatic and sorafenib-resistant capacities. Conclusions: Our findings demonstrate a novel role of ADAR1 as an active regulator for LCSCs properties through editing GLI1 in the highly heterogeneous HCC.
- 24 January 2023
- Published by Wolters Kluwer Health in Hepatology
- Vol. 79 (1) , 61-78
Enhanced mitophagy driven by ADAR1-GLI1 editing supports the self-renewal of cancer stem cells in HCC
Background and Aims: Deregulation of adenosine-to-inosine editing by adenosine deaminase acting on RNA 1 (ADAR1) leads to tumor-specific transcriptome diversity with prognostic values for HCC. However, ADAR1 editase-dependent mechanisms governing liver cancer stem cell (LCSC) generation and maintenance have remained elusive. Approach and Results: RNA-seq profiling identified ADAR1-responsive recoding editing events in HCC and showed editing frequency of GLI1, rather than transcript abundance was clinically relevant. Functional differences in LCSC self-renewal and tumor aggressiveness between wild-type (GLI1wt) and edited GLI1 (GLI1edit) were elucidated. We showed that overediting of GLI1 induced an arginine-to-glycine (R701G) substitution, augmenting tumor-initiating potential and exhibiting a more aggressive phenotype. GLI1R701G harbored weak affinity to SUFU, which in turn, promoted its cytoplasmic-to-nuclear translocation to support LCSC self-renewal by increased pluripotency gene expression. Moreover, editing predisposed to stabilize GLI1 by abrogating β-TrCP-GLI1 interaction. Integrative analysis of single-cell transcriptome further revealed hyperactivated mitophagy in ADAR1-enriched LCSCs. GLI1 editing promoted a metabolic switch to oxidative phosphorylation to control stress and stem-like state through PINK1-Parkin-mediated mitophagy in HCC, thereby conferring exclusive metastatic and sorafenib-resistant capacities. Conclusions: Our findings demonstrate a novel role of ADAR1 as an active regulator for LCSCs properties through editing GLI1 in the highly heterogeneous HCC.
- RetractionOpen Access
- 5 October 2021
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 14, 5003-5004
Long Noncoding RNA Sox2 Overlapping Transcript (SOX2OT) Promotes Non-Small-Cell Lung Cancer Migration and Invasion via Sponging microRNA 132 (miR-132) [Retraction]
Retraction for the article Long noncoding RNA Sox2 overlapping transcript (SOX2OT) promotes non-small-cell lung cancer migration and invasion via sponging microRNA 132 (miR-132)
- 5 October 2021
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 14, 5003-5004
RetractionOpen AccessLong Noncoding RNA Sox2 Overlapping Transcript (SOX2OT) Promotes Non-Small-Cell Lung Cancer Migration and Invasion via Sponging microRNA 132 (miR-132) [Retraction]
Retraction for the article Long noncoding RNA Sox2 overlapping transcript (SOX2OT) promotes non-small-cell lung cancer migration and invasion via sponging microRNA 132 (miR-132)
- Open Access
- 22 June 2011
- Published by Elsevier in The Journal of Physiological Sciences
- Vol. 61 (5) , 363-372
Protective effect of oxymatrine on chronic rat heart failure
- 22 June 2011
- Published by Elsevier in The Journal of Physiological Sciences
- Vol. 61 (5) , 363-372
Open AccessProtective effect of oxymatrine on chronic rat heart failure